Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 69976 - 70000 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	CLMN	79789	downregulated	Silicon Dioxide analog results in decreased expression of CLMN mRNA	14q32.13	A24195
Silicon dioxide	Approved	CLMP	79827	upregulated	Silicon Dioxide analog results in increased expression of CLMP mRNA	11q24.1	A24195
Silicon dioxide	Approved	CLN6	54982	upregulated	Silicon Dioxide analog results in increased expression of CLN6 mRNA	15q23	A24195
Silicon dioxide	Approved	CLSPN	63967	downregulated	Silicon Dioxide analog results in decreased expression of CLSPN mRNA	1p34.3	A24194 A24195
Silicon dioxide	Approved	CLU	1191	upregulated	Silicon Dioxide results in increased expression of CLU mRNA	8p21.1	A24196
Silicon dioxide	Approved	CLUAP1	23059	downregulated	Silicon Dioxide results in decreased expression of CLUAP1 mRNA	16p13.3	A24196
Silicon dioxide	Approved	CLYBL	171425	downregulated	Silicon Dioxide analog results in decreased expression of CLYBL mRNA	13q32.3	A24195
Silicon dioxide	Approved	CNDP1	84735	upregulated	Silicon Dioxide analog results in increased expression of CNDP1 mRNA	18q22.3	A24194
Silicon dioxide	Approved	CNGA4	1262	upregulated	Silicon Dioxide analog results in increased expression of CNGA4 mRNA	11p15.4	A24195
Silicon dioxide	Approved	CNIH3	149111	upregulated	Silicon Dioxide analog results in increased expression of CNIH3 mRNA	1q42.12	A24194
Silicon dioxide	Approved	CNN1	1264	upregulated	Silicon Dioxide analog results in increased expression of CNN1 mRNA	19p13.2	A24194
Silicon dioxide	Approved	CNNM2	54805	downregulated	Silicon Dioxide analog results in decreased expression of CNNM2 mRNA	10q24.32	A24195
Silicon dioxide	Approved	CNOT4	4850	upregulated	Silicon Dioxide analog results in increased expression of CNOT4 mRNA	7q33	A24195
Silicon dioxide	Approved	CNR1	1268	downregulated	Silicon Dioxide analog results in decreased expression of CNR1 mRNA	6q15	A24195
Silicon dioxide	Approved	CNR1	1268	downregulated	Silicon Dioxide results in decreased expression of CNR1 mRNA	6q15	A24197
Silicon dioxide	Approved	CNTN1	1272	downregulated	Silicon Dioxide analog results in decreased expression of CNTN1 mRNA	12q12	A24195
Silicon dioxide	Approved	CNTN3	5067	upregulated	Silicon Dioxide analog results in increased expression of CNTN3 mRNA	3p12.3	A24194
Silicon dioxide	Approved	CNTNAP3	79937	downregulated	Silicon Dioxide analog results in decreased expression of CNTNAP3 mRNA	9p12	A24195
Silicon dioxide	Approved	CNTNAP3B	728577	upregulated	Silicon Dioxide analog results in increased expression of CNTNAP3B mRNA	9p11.2	A24195
Silicon dioxide	Approved	CNTNAP5	129684	upregulated	Silicon Dioxide analog results in increased expression of CNTNAP5 mRNA	2q14.3	A24195
Silicon dioxide	Approved	COA7	65260	upregulated	Silicon Dioxide analog results in increased expression of COA7 mRNA	1p32.3	A24195
Silicon dioxide	Approved	COL10A1	1300	downregulated	Silicon Dioxide analog results in decreased expression of COL10A1 mRNA	6q22.1	A24195
Silicon dioxide	Approved	COL11A1	1301	downregulated	Silicon Dioxide results in decreased expression of COL11A1 mRNA	1p21.1	A24197
Silicon dioxide	Approved	COL13A1	1305	upregulated	Silicon Dioxide analog results in increased expression of COL13A1 mRNA	10q22.1	A24195
Silicon dioxide	Approved	COL16A1	1307	upregulated	Silicon Dioxide analog results in increased expression of COL16A1 mRNA	1p35.2	A24195

Displaying entries 69976 - 70000 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability